AIDS-related Kaposi sarcoma: Clinical Trials

43 trials for AIDS-related Kaposi sarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

30 completed, 7 terminated, 3 withdrawn, 1 not yet recruiting. 20 Phase 2, 18 Phase 1, 4 Phase 3, 3 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 220Completed 13, Terminated 3, Withdrawn 2, Recruiting 1, Unknown 1
Phase 118Completed 12, Terminated 6
Phase 34Completed 3, Not yet recruiting 1
Not applicable3Completed 2, Withdrawn 1

Follow AIDS-related Kaposi sarcoma: new trials by email Literature Review of AIDS-related Kaposi sarcoma trials Research Report on AIDS-related Kaposi sarcoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Nirogacestat in Patients With Kaposi Sarcoma
Biospecimen Collection, Chest Radiography, Computed Tomography - AIDS-Related Kaposi Sarcoma, Skin Kaposi Sarcoma
Phase 2RecruitingAIDS Malignancy Consortium282026-10-132026-10-20
Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma
Pegylated liposomal doxorubicin, Paclitaxel - Kaposi Sarcoma, HIV-1-infection
Phase 3Not yet recruitingAIDS Malignancy Consortium1302026-09-012026-01-23
Doxil/Caelyx BE Study
DOXIL/CAELYX - Ovarian Cancer, AIDS-related Kaposi Sarcoma
Phase 1CompletedBaxter Healthcare Corporation362023-12-162025-06-05
Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC
Non-Interventional, Non-Interventional Follow-up - HIV-Associated Malignant Neoplasm, HIV Infections
CompletedAIDS Malignancy Consortium4602023-07-252026-08-14
NT-I7 for Kaposi Sarcoma in Patients With or Without HIV
Efineptakin alfa - AIDS-Related Kaposi Sarcoma, HIV Infection
Phase 1TerminatedFred Hutchinson Cancer Center82022-05-232024-06-27
Evaluation of Advanced HIV Disease Differentiated Care Model in Malawi
Enhanced package for AHD care - Opportunistic Infections, HIV-Related, Cryptococcal Infections
Not applicableCompletedElizabeth Glaser Pediatric AIDS Foundation7002021-06-012026-09-10
Evaluating Quality of Life in Patients With AIDS-Associated Kaposi Sarcoma Treated With Bleomycin and Vincristine
Bleomycin Sulfate, Laboratory Biomarker Analysis, Quality-of-Life Assessment - AIDS-Related Kaposi Sarcoma, Human Immunodeficiency Virus 1 Positive
CompletedAIDS Malignancy Consortium102018-10-102026-02-11
Gamma Secretase Inhibitor PF-03084014 in Treating Patients With AIDS-Associated Kaposi Sarcoma
gamma secretase inhibitor PF-03084014, pharmacological study, laboratory biomarker analysis - AIDS-related Kaposi Sarcoma, HIV Infection
Phase 2WithdrawnAIDS Malignancy Consortium2015-07-012015-07-23
A Study of Selumetinib in Patients With Kaposi's Sarcoma
Selumetinib - AIDS-related Kaposi's Sarcoma
Phase 1 / Phase 2TerminatedSheffield Teaching Hospitals NHS Foundation Trust192012-06-152019-02-20
Lenalidomide in Treating Patients With AIDS-Associated Kaposi's Sarcoma
Lenalidomide - AIDS-Related Kaposi Sarcoma, Recurrent Kaposi Sarcoma
Phase 1 / Phase 2CompletedNational Cancer Institute (NCI)382010-08-272022-02-08
Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma
Bortezomib, Laboratory Biomarker Analysis, Questionnaire Administration - AIDS-Related Kaposi Sarcoma, HIV Infection
Phase 1CompletedNational Cancer Institute (NCI)242010-01-222018-02-20
Sunitinib Malate in Treating East African Patients With Kaposi Sarcoma
sunitinib malate, laboratory biomarker analysis, pharmacological study - AIDS-related Kaposi Sarcoma, Classic Kaposi Sarcoma
Phase 2WithdrawnNational Cancer Institute (NCI)2009-01-012014-05-05
PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma
VEGF inhibitor PTC299, gene expression analysis, polymerase chain reaction - Kaposi's Sarcoma
Phase 1 / Phase 2TerminatedAIDS Malignancy Consortium172008-09-012018-06-06
Liposomal Daunorubicin in Treating Patients With HIV-Related Kaposi's Sarcoma
liposomal daunorubicin citrate - Sarcoma
Phase 1TerminatedAIDS Malignancy Consortium142008-09-012015-04-29
Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
polymerase chain reaction, cytology specimen collection procedure, histological technique - Aids-related Malignancies, Lymphoma
CompletedAIDS Malignancy Consortium472008-05-142020-08-10
Sirolimus in Treating Patients With HIV-Related Kaposi's Sarcoma
sirolimus - Sarcoma
Phase 1CompletedAIDS Malignancy Consortium72007-10-012014-08-29
A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi's Sarcoma in Zimbabwe
abacavir/3TC/zidovudine, abacavir /3TC plus ritonavir boosted lopinavir - AIDS-related Kaposi's Sarcoma
Phase 2 / Phase 3CompletedParirenyatwa Hospital492007-06-012014-10-30
Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas
sunitinib malate - Adult Malignant Fibrous Histiocytoma of Bone, Desmoid Tumor
Phase 2CompletedMemorial Sloan Kettering Cancer Center532007-04-012016-01-20
Imatinib Mesylate in Treating Patients With HIV-Related Kaposi's Sarcoma
imatinib mesylate - Sarcoma
Phase 2CompletedAIDS Malignancy Consortium302005-06-012018-06-06
Valproic Acid in Treating Patients With Kaposi's Sarcoma
valproic acid - Sarcoma
Not applicableCompletedAIDS Malignancy Consortium192005-02-012014-08-29

Showing 20 of 43. Sign in to see all of them.

Narrower conditions

Sarcoma, Kaposi (30)  ·  Sarcoma (24)  ·  HIV Infections (8)  ·  Osteosarcoma (6)  ·  Acquired Immunodeficiency Syndrome (5)  ·  Breast Neoplasms (5)  ·  Chondrosarcoma (5)  ·  Esthesioneuroblastoma, Olfactory (5)  ·  Lymphoma (5)  ·  Neoplasms (5)  ·  Neuroectodermal Tumors, Primitive, Peripheral (5)  ·  Ovarian Neoplasms (5)  ·  Squamous Cell Carcinoma of Head and Neck (5)  ·  Carcinoma, Non-Small-Cell Lung (4)

Broader conditions

Neoplasms by Histologic Type (36)  ·  Neoplasms, Connective and Soft Tissue (34)  ·  Virus Diseases (34)  ·  Infections (33)  ·  DNA Virus Infections (31)  ·  Neoplasms (31)  ·  Herpesviridae Infections (30)  ·  Neoplasms, Vascular Tissue (30)  ·  Urogenital Diseases (19)  ·  Genital Diseases (18)  ·  Immune System Diseases (18)  ·  Blood-Borne Infections (12)  ·  Communicable Diseases (12)  ·  Immunologic Deficiency Syndromes (12)  ·  Lentivirus Infections (12)

Interventions

Paclitaxel (4)  ·  liposomal doxorubicin (4)  ·  Daunorubicin (2)  ·  Docetaxel (2)  ·  Etoposide (2)  ·  Filgrastim (2)  ·  Polymerase Chain Reaction (2)  ·  Semaxinib (2)  ·  Sunitinib (2)  ·  Thalidomide (2)  ·  nirogacestat (2)  ·  AZD 6244 (1)  ·  Altretamine (1)  ·  Amifostine (1)  ·  Analgesia (1)

Sponsors

AIDS Malignancy Consortium (12)  ·  National Cancer Institute (NCI) (12)  ·  Case Comprehensive Cancer Center (2)  ·  Eastern Cooperative Oncology Group (2)  ·  Memorial Sloan Kettering Cancer Center (2)  ·  Roswell Park Cancer Institute (2)  ·  Baxter Healthcare Corporation (1)  ·  Centro di Riferimento Oncologico - Aviano (1)  ·  Dana-Farber Cancer Institute (1)  ·  Dartmouth-Hitchcock Medical Center (1)  ·  Elizabeth Glaser Pediatric AIDS Foundation (1)  ·  Fred Hutchinson Cancer Center (1)  ·  National Institutes of Health Clinical Center (CC) (1)  ·  Parirenyatwa Hospital (1)  ·  Pfizer (1)

Countries

United States (33)  ·  Brazil (1)  ·  India (1)  ·  Italy (1)  ·  Malawi (1)  ·  Puerto Rico (1)  ·  Tanzania (1)  ·  United Kingdom (1)  ·  Zimbabwe (1)

Top investigators

Dirk Dittmer, PhD (2)  ·  Jamie Hayden Von Roenn, MD (2)  ·  Lawrence P. Leichman, MD (2)  ·  Lee Ratner (2)  ·  Robert Yarchoan, MD (2)  ·  Scot C. Remick, MD (2)  ·  Susan E. Krown, MD (2)  ·  Alison L. Hannah, MBBS (1)  ·  Anna E Coghill, PhD, MPH (1)  ·  Appolinaire Tiam, MBChB, MMed, PhD (1)  ·  Ariela Noy, MD (1)  ·  Barbara J. Klencke, MD (1)  ·  Bruce Dezube (1)  ·  David Straus, MD (1)

Results publications

PMID 10893291, PMID 17846226, PMID 18224669, PMID 18470481, PMID 19451429, PMID 20407240, PMID 27002157, PMID 35247913, PMID 38041058, PMID 39915263, PMID 41286911

NIH funding

U01CA070019 (6), U01CA121947 (6), UM1CA121947 (4), P30CA043703 (2), U01CA062502 (2), P30AI036219 (1), P30CA006516 (1), P30CA008748 (1), P30CA023108 (1), U10CA021115 (1), UM1CA154967 (1)